Table 4.
HTN-IR (n = 652) | MACAD (n = 774) | P | |
---|---|---|---|
Age, y | 34.2 (19.4) | 34.0 (13.8) | < .0001 |
Sex, female % | 58.0% | 57.3% | .79 |
IGI30, pmol/mmol | N/A | 142.7 (153.5) | N/A |
M, µmol·min–1·m–2 | 1217.3 (801.0) | 1293.9 (827.1) | .03 |
MCRI, ml·m–2·min–1 | 442.7 (126.7) | 470.0 (146.3) | .02 |
BMI, kg/m2 | 28.0 (6.9) | 28.2 (6.3) | .37 |
BAI, % | 32.0 (9.0) | 31.5 (8.4) | .96 |
Body fat, kg | N/A | 23.7 (11.3) | N/A |
HDL-C, mmol/l | 1.19 (0.44) | 1.16 (0.39) | .009 |
Triglycerides, mmol/l | 1.08 (0.92) | 1.22 (1.03) | .001 |
Data are median (interquartile range) except for sex. Body fat and IGI30 were available only in MACAD participants.
Abbreviations: BAI, body adiposity index; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; HTN-IR, Hypertension–Insulin Resistance cohort; IGI30, insulinogenic index at 30 minutes; M, glucose infusion rate; MACAD, Mexican-American Coronary Artery Disease Study; MCRI, metabolic clearance rate of insulin; N/A, not available.